Endometrial Cancer: Managing Toxicities in Lenvatinib and Pe

Discover strategies for minimizing adverse events and overlapping toxicities in patients undergoing lenvatinib and pembrolizumab therapy for recurrent endometrial cancer.

Related Keywords

, Optimizing Therapy , Endometrial Cancer , Recent Data Highlights , Managing Toxicities , Lenvatinib , Pembrolizumab , Adverse Events , Toxicities , Supportive Care , Treatment Strategies , Diarrhea , Hypertension , Medication Management , Dose Adjustment , Patient Comfort , Overlapping Toxicities , Pcp Collaboration , Side Effect Management ,